Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Contemp Clin Trials. 2017 Jan 27;55:24–33. doi: 10.1016/j.cct.2017.01.006

Table 2.

Mediators Time Points* Original Source
Medication-taking Self-efficacy 1, 2, 3 Perceived Competence Scale48
Autonomous Motivation 1, 2, 3 Treatment Self-Regulation Questionnaire (TSRQ)49
Medication adherence 1, 2, 3 Morisky Medication Adherence Measure50
Assessment of level and type of support received by Peer coach 2, 3 Process measures used in P2P and by Robert Wood Johnson Foundation Diabetes Initiative18
Self-efficacy for shared decision-making with providers 1, 2, 3 Self-efficacy for Decision-making scale51
Medication doses and insulin starts 1, 2, 3 Survey items and electronic medical records
Moderators/Engagement Factors
Race 1 2010 US Census measures
Preferred and actual decision-making with providers 1 Preferred and Actual Participation in Decision-making Scales52
Attachment Style 1 Relationship Questionnaire53
Perceived Need for DM self-management support 1 Support Needs Scale from Diabetes Care Profile54
Perceived Benefits and Barriers to Taking DM medications 1 Two subscales from instrument assessing perceived barriers to and benefits from taking diabetes medications based on health beliefs model55
Health Literacy 1 Functional Health Literacy Screener7
Numeracy 1 Subjective Numeracy Scale (SNS)56
Food insecurity 1 Food Security Survey Module57
Neighborhood Safety, Availability of Healthy Foods, and Walking Environment 1 Neighborhood Safety Measure, Availability of Healthy Foods, Walking Environment58
*

Time point 1 is baseline, 2 is at 6 months, 3 is at 12 months.